Frequently asked questions to the 2023 obesity medicine association position statement on compounded peptides: A call for action.

Bays HE, Fitch A, Francavilla Brown C, Younglove C, Christensen SM, Alexander LC

Open source

DOI
10.1016/j.obpill.2024.100122
Published
2024 Sep
Container
Obesity pillars
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.obpill.2024.100122,
  title = {Frequently asked questions to the 2023 obesity medicine association position statement on compounded peptides: A call for action.},
  author = {Bays HE and Fitch A and Francavilla Brown C and Younglove C and Christensen SM and Alexander LC},
  year = {2024},
  journal = {Obesity pillars},
  doi = {10.1016/j.obpill.2024.100122},
  url = {https://doi.org/10.1016/j.obpill.2024.100122}
}

RIS

TY  - JOUR
TI  - Frequently asked questions to the 2023 obesity medicine association position statement on compounded peptides: A call for action.
AU  - Bays HE
AU  - Fitch A
AU  - Francavilla Brown C
AU  - Younglove C
AU  - Christensen SM
AU  - Alexander LC
PY  - 2024
JO  - Obesity pillars
DO  - 10.1016/j.obpill.2024.100122
UR  - https://doi.org/10.1016/j.obpill.2024.100122
ER  - 

APA

HE, B., A, F., C, F. B., C, Y., SM, C., & LC, A. (2024). Frequently asked questions to the 2023 obesity medicine association position statement on compounded peptides: A call for action.. Obesity pillars. https://doi.org/10.1016/j.obpill.2024.100122

Source records